MTMaurizio S. Tonetti

Maurizio S. Tonetti

*This is an algorithmically generated author record based on publicly available information.

Maurizio S. Tonetti has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Peri-implantitis: etiology, pathogenesis, prevention, and therapy

    by Niklaus P. Lang, H.C. Mult., Maurizio S. Tonetti


  • Open Access

    Seventh European Workshop on Periodontology of the European Academy of Periodontology at the Parador at La Granja, Segovia, Spain

    by Mariano Sanz, Niklaus P. Lang, Denis F. Kinane, Tord Berglundh, Iain Chapple, Maurizio S. Tonetti


    • 1 June 2009
      • Vol. 29  (3) , 257-65

    Minimally invasive surgical technique and enamel matrix derivative in intrabony defects: 2. Factors associated with healing outcomes.

    by Pierpaolo Cortellini, Giovanpaolo Pini-Prato, Michele Nieri, Maurizio S Tonetti

    This case cohort study was designed to evaluate the healing response of a minimally invasive surgical technique (MIST) in combination with enamel matrix derivative (EMD) in isolated deep intrabony defects. Forty deep intrabony defects were surgically accessed with the MIST This technique was designed to limit the flap extent and reflection to reduce surgical trauma and increase flap stability. EMD was applied on the dried root surfaces. Surgery was performed with the aid of an operating microscope and microsurgical instruments. The 1-year clinical attachment level gain was 4.9 +/- 1.7 mm. Seventy percent of defects gained > or = 4 mm. Clinical attachment level gain was significantly associated with the depth of the three-wall component of the defect, with the intraoperative bleeding tendency of the defect, and with its interaction with the baseline amount of bone loss. Defect morphology and bleeding tendency seem to influence clinical outcomes from the use of MIST in combination with EMD.


  • Acute effects of periodontal therapy on bio‐markers of vascular health

    by Francesco D'Aiuto, M. Parkar, Maurizio S. Tonetti

    Aim: We aimed to study the impact of periodontal therapy on several bio‐markers related to vascular health.Material and Methods: Fifty‐five consecutive subjects (age range 30–64 years) having severe periodontitis received an intensive session of periodontal therapy under local anaesthesia and provided blood samples before and 1 and 7 and 30 days following therapy. High‐sensitivity assays were utilized to quantify serum concentrations of inflammatory markers [interleukin(IL)‐1β, tumour necrosis factor‐α], plasma haemostatic (D‐dimer) and endothelial soluble markers [soluble E‐selectin(s‐Es) and von Willebrand factor antigen (r‐WF:Ag)].Results: Periodontal therapy elicited a significant activation of the haemostatic system (38% and 68% mean increases of plasma D‐dimer 1 and 7 days after therapy, respectively, ppppβ (pppConclusions: Periodontal therapy represents a novel and reliable non‐drug‐induced model to investigate in vivo the interplay between inflammation, coagulation and endothelial cell activation.


  • Guided tissue regeneration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: radiographic predictors and outcomes

    by Antonio Liñares, Pierpaolo Cortellini, Niklaus P. Lang, Jean Suvan, Maurizio S. Tonetti, on behalf of the European Research Group on Periodontology (ErgoPerio)

    Objectives: This study reports the secondary analysis of a randomized‐controlled clinical trial designed to assess the efficacy of deproteinized bovine mineral and a collagen membrane in the treatment of intrabony defects. The specific aims of this report are (1) to analyse the radiographic bone changes 1 year after therapy and (2) to assess the association between radiographic defect angle and treatment outcomes.Materials and Methods: Baseline and 12‐month radiographs were collected from 120 patients with advanced chronic periodontitis from 10 centres in seven countries as part of a multi‐centre clinical trial. All patients had at least one intrabony defect 3 mm in depth. The treatment consisted of simplified or modified papilla preservation flaps to access the defect. After debridement of the area, a deproteinized bovine mineral and a collagen membrane were applied in the test subjects, and omitted in the controls. Main outcome measures were radiographic bone fill and defect resolution 1 year after surgery.Results: One hundred and twenty pairs of radiographs were obtained, of which 110 pairs were measurable (57 tests and 53 controls). One year after treatment, radiographic resolution of the intrabony component was significantly higher in the test group (3.2±1.7 mm) when compared with the controls (1.7±1.9 mm). Multivariate analysis indicated that the treatment and the baseline radiographic depth of the intrabony defect significantly influenced the radiographic bone fill of the intrabony defect 1 year following treatment. The percentage of resolution of the defect was influenced by the treatment provided and the baseline plaque score. The baseline radiographic defect angle did not show a significant impact on the clinical and radiographic outcomes.Conclusions: Regenerative periodontal surgery with a deproteinized bovine bone mineral and a collagen membrane offered additional benefits in terms of radiographic resolution of the intrabony defect and predictability of outcomes with respect to papilla preservation flaps alone.


  • Supportive periodontal therapy using mechanical instrumentation or 2% minocycline gel: a 12 month randomized, controlled, single masked pilot study

    by E. McColl, K. Patel, G. Dahlen, M. Tonetti, F. Graziani, J. Suvan, L. Laurell

    Objective: To compare the short‐term performance of subgingival local delivery of 2% minocycline gel and conventional subgingival debridement in supportive periodontal therapy (SPT) patients.Methods: Forty adult patients having completed active treatment for moderate to advanced chronic periodontitis were included in a randomized, controlled, single masked maintenance care pilot study. Sites with residual pocket probing depths 5 mm and bleeding on probing were treated with either minocycline gel (minocycline‐group) or scaling and root planing only (debridement‐group) at baseline, 3, 6, and 9 months. Clinical and microbiological examinations were performed at baseline, 3, 6, 9, and 12 months.Results: Full‐mouth plaque and bleeding scores remained pPorphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Actinobacillus actinomycetemcomitans, Prevotella intermedia, and Prevotella nigrescens, remained at levels 105 in the majority of patients and sites in both groups.Conclusion: This pilot study failed to show a difference between local delivery of 2% minocycline gel as mono‐therapy and traditional subgingival debridement in patients on SPT.


  • Microbial colonization patterns predict the outcomes of surgical treatment of intrabony defects

    by Lisa Heitz‐Mayfield, Maurizio S. Tonetti, Pierpaolo Cortellini, Niklaus P. Lang, on behalf of European Research Group on Periodontology (ERGOPERIO)

    Aim: To explore the impact of bacterial load and microbial colonization patterns on the clinical outcomes of periodontal surgery at deep intrabony defects.Materials and Methods: One hundred and twenty‐two patients with advanced chronic periodontitis and at least one intrabony defect of >3 mm were recruited in 10 centres. Before recruitment, the infection control phase of periodontal therapy was completed. After surgical access and debridement, the regenerative material was applied in the test subjects, and omitted in the controls. At baseline and 1 year following the interventions, clinical attachment levels (CAL), pocket probing depths (PPD), recession (REC), full‐mouth plaque scores and full‐mouth bleeding scores were assessed. Microbial colonization of the defect‐associated pocket was assessed using a DNA–DNA checkerboard analysis.Results: Total bacterial load and counts of red complex bacteria were negatively associated with CAL gains 1 year following treatment. The probability of achieving above median CAL gains (>3 mm) was significantly decreased by higher total bacterial counts, higher red complex and T. forsythensis counts immediately before surgery.Conclusions: Presence of high bacterial load and specific periodontal pathogen complexes in deep periodontal pockets associated with intrabony defects had a significant negative impact on the 1 year outcome of surgical/regenerative treatment.


  • Adjunctive benefits of systemic amoxicillin and metronidazole in non‐surgical treatment of generalized aggressive periodontitis: a randomized placebo‐controlled clinical trial

    by Adrian Guerrero, Gareth S. Griffiths, Luigi Nibali, Jean Suvan, David R. Moles, Lars Laurell, Maurizio S. Tonetti

    Background: The objective of this study was to assess the adjunctive clinical effect of the administration of systemic amoxicillin and metronidazole in the non‐surgical treatment of generalized aggressive periodontitis (GAP).Methods: Forty‐one systemically healthy subjects with GAP were included in this 6‐month double‐blind, placebo‐controlled, randomized clinical trial. Patients received a course of full‐mouth non‐surgical periodontal treatment delivered over a 24 h period using machine‐driven and hand instruments. Test subjects received an adjunctive course of systemic antibiotic consisting of 500 mg amoxicillin and 500 mg metronidazole three times a day for 7 days. Clinical parameters were collected at baseline, and at 2 and 6 months post‐treatment.Results: In both the test and the placebo groups, all clinical parameters improved at 2 and 6 months. In deep pockets (7 mm), the test treatment resulted in an additional 1.4 mm (95% confidence interval 0.8, 2.0 mm) in full‐mouth probing pocket depth (PPD) reduction and 1 mm (0.7, 1.3 mm) of life cumulative attachment loss (LCAL) gain at 6 months. In moderate pockets (4–6 mm), the adjunctive benefit was smaller in magnitude: PPD reduction was 0.4 mm (0.1, 0.7 mm) and LCAL gain was 0.5 mm (0.2, 0.8 mm). In addition, the 6‐month data showed LCAL gains 2 mm at 25% of sites in test patients compared with 16% in placebo (p=0.028). Similarly, PPD reductions of 2 mm or more were observed in 30% of sites in test and 21% of sites in placebo patients. Seventy‐four percent of pockets with PPD 5 mm at baseline were 4 mm or shallower at 6 months in the test group. This compared with 54% in the placebo group (p=0.008). Disease progression at 6 months was observed at 1.5% of test and 3.3% of sites in test and placebo, respectively (p=0.072).Conclusions: These data indicate that a 7‐day adjunctive course of systemic metronidazole and amoxicillin significantly improved the short‐term clinical outcomes of full‐mouth non‐surgical periodontal debridement in subjects with GAP.